Golden Helix to Attend AMP 2025 in Boston

         October 30, 2025

Golden Helix is excited to exhibit at the Association for Molecular Pathology (AMP) 2025 Annual Meeting in Boston, Massachusetts, where we’ll showcase our newest advancements in variant interpretation, enterprise genomics, and scalable software deployment.

Visit us at Booth #543 to explore how VSWarehouse and our Bring Your Own Cloud (BYOC) solution enable laboratories to deploy secure, scalable, and compliant cloud-based genomic analysis environments. Our enterprise platform seamlessly integrates with existing LIMS and EHR systems, automates high-throughput sequencing workflows, and centralizes variant data to support efficient and reproducible clinical interpretation.

See Our Software in Action

Throughout the exhibition, our team will host live demonstrations highlighting the power and versatility of the Golden Helix software suite:

Thursday, November 13

  • 12:00 PM – Streamlining Cancer Analysis with Oncogenicity Classifier and CancerKB
  • 12:45 PM – Whole Genome Analysis with Long Read Data
  • 2:20 PM – NGS Enterprise Capabilities: Automation, Integration, Warehousing
  • 3:35 PM – PGx: Pharmacogenomics Workflow
  • 4:15 PM – Enhancing Your Cancer Analysis with Genomenon CKB

Friday, November 14

  • 9:25 AM – Streamlining Cancer Analysis with Oncogenicity Classifier and CancerKB
  • 12:00 PM – Whole Genome Analysis with Long Read Data
  • 12:45 PM – NGS Enterprise Capabilities: Automation, Integration, Warehousing
  • 3:00 PM – PGx: Pharmacogenomics Workflow
  • 3:30 PM – Enhancing Your Cancer Analysis with Genomenon CKB

Saturday, November 15

  • 9:20 AM – Streamlining Cancer Analysis with Oncogenicity Classifier and CancerKB
  • 10:00 AM – Whole Genome Analysis with Long Read Data
  • 12:00 PM – NGS Enterprise Capabilities: Automation, Integration, Warehousing
  • 12:40 PM – Enhancing Your Cancer Analysis with Genomenon CKB

Driving Scalable Precision Genomics

Golden Helix’s end-to-end software solutions are built to scale with the evolving demands of molecular diagnostics, from variant annotation and classification to full enterprise deployment. Whether you’re interested in streamlining cancer analysis, automating pharmacogenomics workflows, or managing cohort-level variant data, our platform delivers powerful, integrated tools that help laboratories translate NGS data into actionable insights.

Visit Golden Helix at Booth #543 to learn how our solutions can enhance your laboratory’s efficiency, accuracy, and scalability.

Leave a Reply

Your email address will not be published. Required fields are marked *